IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus
暂无分享,去创建一个
O. Aydemir | Sean M McCauley | Mehmet H Guney | C. Carbone | Jeremy Luban | Karthika Nagalekshmi | Ozkan Aydemir | S. McCauley | M. H. Guney
[1] Michael T. Lu,et al. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. , 2023, The New England journal of medicine.
[2] R. Siliciano,et al. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy , 2023, The Journal of clinical investigation.
[3] P. Edlefsen,et al. Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation , 2023, medRxiv : the preprint server for health sciences.
[4] L. James,et al. IP6‐stabilised HIV capsids evade cGAS/STING‐mediated host immune sensing , 2023, EMBO reports.
[5] J. Clements,et al. Monocyte-derived macrophages contain persistent latent HIV reservoirs , 2023, Nature Microbiology.
[6] Xu G. Yu,et al. Cooperation between cGAS and RIG-I sensing pathways enables improved innate recognition of HIV-1 by myeloid dendritic cells in elite controllers , 2022, Frontiers in Immunology.
[7] B. Hahn,et al. Evasion of cGAS and TRIM5 defines pandemic HIV , 2022, Nature Microbiology.
[8] S. Valente,et al. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A. , 2021, The Journal of infectious diseases.
[9] N. Lin,et al. HIV-1 transcription but not intact provirus levels are associated with systemic inflammation. , 2020, The Journal of infectious diseases.
[10] G. Hartmann,et al. Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells , 2020, Proceedings of the National Academy of Sciences.
[11] Matthew D. Edwards,et al. Determination of RNA structural diversity and its role in HIV-1 RNA splicing , 2020, Nature.
[12] Lawrence M. Lifshitz,et al. HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells , 2019, Nature Immunology.
[13] A. Vos,et al. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. , 2019, The New England journal of medicine.
[14] M. Peeters,et al. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. , 2019, The New England journal of medicine.
[15] Onur Yukselen,et al. DolphinNext: a distributed data processing platform for high throughput genomics , 2019, BMC Genomics.
[16] G. Melikyan,et al. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing , 2019, Journal of Virology.
[17] B. Walker. Faculty Opinions recommendation of A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[18] J. Luban,et al. Cyclophilin A protects HIV-1 from restriction by human TRIM5α , 2019, Nature Microbiology.
[19] Abraham J. Kandathil,et al. No recovery of replication-competent HIV-1 from human liver macrophages , 2018, The Journal of clinical investigation.
[20] A. Belkina,et al. HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction , 2018, Nature Communications.
[21] A. Aderem,et al. Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection. , 2018, Cell host & microbe.
[22] Lloyd M. Smith,et al. Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry , 2017, Scientific Reports.
[23] J. Luban,et al. Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines , 2017, Nature Communications.
[24] R. El-Diwany,et al. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals , 2017, AIDS.
[25] J. Mellors,et al. Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART , 2017, Proceedings of the National Academy of Sciences.
[26] R. Siliciano,et al. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. , 2017, Cell host & microbe.
[27] R. Ribeiro,et al. HIV persistence in tissue macrophages of humanized myeloid only mice during antiretroviral therapy , 2017, Nature Medicine.
[28] H. Gendelman,et al. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy , 2017, Retrovirology.
[29] P. Ganz,et al. Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV , 2016, Journal of the American Heart Association.
[30] Abraham J. Kandathil,et al. Are T cells the only HIV-1 reservoir? , 2016, Retrovirology.
[31] F. Kirchhoff,et al. HIV Triggers a cGAS-Dependent, Vpu- and Vpr-Regulated Type I Interferon Response in CD4+ T Cells. , 2016, Cell reports.
[32] R. Dewar,et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.
[33] R. Siliciano,et al. Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.
[34] B. Walker,et al. Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. , 2016, Immunity.
[35] Jonathan L. Schmid-Burgk,et al. A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2′O-Methylated Self RNA , 2015, Immunity.
[36] T. Hallett,et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study , 2015, The Lancet. Infectious diseases.
[37] J. Margolick,et al. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. , 2015, The Journal of infectious diseases.
[38] J. Margolick,et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.
[39] D. Hafler,et al. TLR7 induces anergy in human CD4+ T cells , 2014, Nature Immunology.
[40] C. Mussini,et al. Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV. , 2014, Immunology letters.
[41] Kenneth C. Williams,et al. The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure , 2014, AIDS.
[42] G. Hartmann,et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates , 2014, Nature.
[43] S. Paludan,et al. T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: Implications for Restriction of HIV Replication , 2014, PloS one.
[44] Sharmin Begum,et al. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells , 2013, eLife.
[45] I. Hurbain,et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. , 2013, Immunity.
[46] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[47] L. James,et al. HIV-1 evades innate immune recognition through specific co-factor recruitment , 2013, Nature.
[48] D. Douek,et al. Systemic effects of inflammation on health during chronic HIV infection. , 2013, Immunity.
[49] Nan Yan,et al. Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses , 2013, Science.
[50] S. Goodbourn,et al. LGP2 Plays a Critical Role in Sensitizing mda-5 to Activation by Double-Stranded RNA , 2013, PloS one.
[51] K. Kraemer,et al. HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.
[52] R. Finberg,et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. , 2013, Immunity.
[53] K. Conzelmann,et al. Paramyxovirus V Proteins Disrupt the Fold of the RNA Sensor MDA5 to Inhibit Antiviral Signaling , 2013, Science.
[54] T. Walz,et al. Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 , 2013, Cell.
[55] Qian Feng,et al. MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells , 2012, Cell Reports.
[56] R. Haubrich,et al. Metabolic Syndrome Before and After Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected Individuals , 2012, Journal of acquired immune deficiency syndromes.
[57] E. Richer,et al. Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses , 2012, Journal of Cell Science.
[58] R. Redfield,et al. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors , 2012, AIDS.
[59] J. Margolick,et al. Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. , 2012, Atherosclerosis.
[60] N. Grishin,et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. , 2012, Immunity.
[61] R. Gorelick,et al. Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA , 2012, PloS one.
[62] Bin Wu,et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition , 2011, Proceedings of the National Academy of Sciences.
[63] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[64] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[65] M. Gale,et al. Immune signaling by RIG-I-like receptors. , 2011, Immunity.
[66] Jeremy Luban,et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.
[67] A. van Dorsselaer,et al. Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K , 2011, RNA biology.
[68] M. Wainberg,et al. RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I , 2010, Journal of Virology.
[69] D. Levy,et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells , 2010, Nature.
[70] R. Sachidanandam,et al. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing , 2010, Proceedings of the National Academy of Sciences.
[71] K. Jeang,et al. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs , 2010, Proceedings of the National Academy of Sciences.
[72] Nicole C. Robb,et al. RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection , 2010, Cell.
[73] S. Akira,et al. Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.
[74] J. Hiscott,et al. RIG-I-like receptors: sensing and responding to RNA virus infection. , 2009, Seminars in immunology.
[75] A. Schmidt,et al. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I , 2009, Proceedings of the National Academy of Sciences.
[76] Osamu Takeuchi,et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.
[77] Kristen K. Dang,et al. Architecture and Secondary Structure of an Entire HIV-1 RNA Genome , 2009, Nature.
[78] C. Horvath,et al. A Shared Interface Mediates Paramyxovirus Interference with Antiviral RNA Helicases MDA5 and LGP2 , 2009, Journal of Virology.
[79] Mario Roederer,et al. Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.
[80] Mila Lebedeva,et al. Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.
[81] S. Goodbourn,et al. Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins , 2008, Journal of Virology.
[82] S. Akira,et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.
[83] S. Goodbourn,et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. , 2007, Virology.
[84] J. Brenchley,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.
[85] Jeffrey N. Martin,et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.
[86] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[87] A. Pichlmair,et al. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.
[88] J. Darlix,et al. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC , 2006, Gene Therapy.
[89] Richard A Flavell,et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[90] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[91] G. Pavlakis,et al. RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs , 2006, Retrovirology.
[92] J. Lifson,et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. , 2005, The Journal of clinical investigation.
[93] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[94] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[95] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[96] J. Mascola,et al. Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells , 2005, Journal of Virology.
[97] Osamu Takeuchi,et al. Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.
[98] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[99] J. Lifson,et al. Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells , 2004, Journal of Virology.
[100] J. Dai,et al. Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.
[101] Jeffrey N. Martin,et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.
[102] T. Rana,et al. Tat stimulates cotranscriptional capping of HIV mRNA. , 2002, Molecular cell.
[103] Paul B. Fisher,et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[104] Antonio Lanzavecchia,et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.
[105] R. Steinman,et al. Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals1 , 2000, The Journal of Immunology.
[106] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[107] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[108] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[109] Minoru Yoshida,et al. CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.
[110] S. Le,et al. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.
[111] J. Sodroski,et al. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[112] D. Symons,et al. Collaborative , 2021, Encyclopedia of the UN Sustainable Development Goals.
[113] V. Kim,et al. fCLIP-seq for transcriptomic footprinting of dsRNA-binding proteins: Lessons from DROSHA. , 2019, Methods.
[114] N. Bhardwaj,et al. Plasmacytoid dendritic cells in HIV infection. , 2013, Advances in experimental medicine and biology.
[115] Z. Zhai,et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.
[116] M. Malim,et al. The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators. , 1991, Trends in biochemical sciences.